APRIL ZUMWALT: Open Payments
NPI 1629375993 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 46 payments from 15 companies in 2025. Trend: 2023 $1,225 · 2024 $1,064 · 2025 $1,038
Food & beverage: $938Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $184 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $162 |
| Novo Nordisk Inc | 9 | $148 |
| Organon LLC | 4 | $90 |
| Lilly USA, LLC | 4 | $86 |
| Sage Therapeutics, LLC | 4 | $76 |
| Exact Sciences Corporation | 3 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| ABIOMED | 1 | $26 |
Products named: BIJUVA, Veozah, NEXPLANON, ZURZUVAE, Ozempic, Cologuard Collection Kit, MOUNJARO, GEMTESA.
Industry payments across OK — which companies pay providers there.
